The European Centre for Disease Prevention and Control is monitoring the situation following the death of a laboratory worker in Russia from suspected pneumonic plague.
The European health agency reported on Tuesday that transmission of pneumonic plague generally requires close and prolonged contact with an infected individual who is already demonstrating symptoms.
Health officials noted that limited information available so far indicates no secondary cases have been reported, and there is no evidence of sustained person-to-person transmission that could trigger wider spread of the disease.
The agency explained that pneumonic plague is a severe infectious disease that spreads through droplets expelled when an infected individual coughs.
Transmission risks and EU preparedness
European health officials highlighted that no cases of pneumonic plague have been registered within the European Union in decades.
The agency emphasized that effective antibiotics capable of treating the infection are readily available across the European Union.
Under medical guidelines, patients with suspected or confirmed pneumonic plague must be isolated immediately and receive appropriate medical treatment as determined by a specialized healthcare professional.
Public health protocols dictate that close contacts of any infected individual must be identified and monitored rapidly to ensure swift containment.
International health monitoring
The European Centre for Disease Prevention and Control confirmed that it will continue to supervise the event as more information becomes available.
The agency added that it remains in proactive contact with European representatives of the World Health Organization to analyze the ongoing situation.
The World Health Organization is also keeping close watch on the case involving the laboratory worker in Russia, following concerns originating in Siberia.
Understanding pneumonic plague
Pneumonic plague is caused by Yersinia pestis, the same bacterium responsible for bubonic plague and septicemic plague.
It is the rarest and most severe form of plague, characterized by a direct or secondary infection of the lungs.
Unlike bubonic plague, which is typically transmitted to humans through flea bites from infected rodents, pneumonic plague can spread directly from person to person via airborne respiratory droplets.
Primary pneumonic plague results from directly inhaling infectious droplets expelled by a coughing patient or infected animal.
Secondary pneumonic plague occurs when the bacterium spreads to the lungs from the bloodstream in patients suffering from untreated bubonic or septicemic plague.
Without early medical intervention, pneumonic plague progresses rapidly and carries a very high fatality rate, though early administration of standard antibiotics significantly improves patient outcomes.
Symptoms of pneumonic plague usually develop within one to three days after exposure and typically include sudden fever, headache, muscle weakness, chest pain, coughing, and bloody sputum.
Biosafety and public health response
Laboratory facilities that handle dangerous bacterial pathogens such as Yersinia pestis follow strict biosafety protocols, including specialized air filtration and protective equipment, to prevent accidental exposure.
Standard outbreak containment measures rely on rapid contact tracing, isolation of cases, and preventative antibiotic therapy for individuals who had close contact with an infected patient.
Common antibiotics used to treat or prevent plague infections include streptomycin, gentamicin, doxycycline, and ciprofloxacin.
The European Centre for Disease Prevention and Control, based in Stockholm, Sweden, is an agency of the European Union responsible for monitoring infectious disease threats and advising member states on public health measures.
The World Health Organization operates as the public health agency of the United Nations, providing global disease surveillance and international coordination during potential health emergencies.
Siberia is a vast region in eastern Russia known for housing specialized scientific research facilities and environmental monitoring stations across its territories.
